Monthly Archives: February 2013

February 22, 2013

2013 induced pluripotent stem cells (iPSC) industry report – market trends, metrics, and financials

Bharat Book Bureau has recently added the market intelligence report titled “The Complete 2012-13 Induced Pluripotent Stem Cell Industry Report – Market Metrics, Dynamics, and Trends.” It provides strategic insights that guide the decision-making of companies that develop and manufacture … Read More



 
 

February 21, 2013

Dealing with the unexpected: Consumer responses to direct access BRCA mutation testing

Inherited BRCA gene mutations convey a high risk for breast and ovarian cancer, but current guidelines limit BRCA mutation testing to women with early-onset cancer and relatives of mutation-positive cases. Benefits and risks of providing this information directly to consumers … Read More



 
 

February 19, 2013

Embryonic and induced pluripotent stem cells: Understanding, creating, and exploiting the nano-niche for regenerative medicine

Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) have the capacity to differentiate into any specialized cell type of the human body, and therefore, ESC/iPSC-derived cell types offer great potential for regenerative medicine. However, key to realizing this … Read More